148
Participants
Start Date
October 31, 2008
Primary Completion Date
November 30, 2009
Study Completion Date
December 31, 2009
recombinant human hyaluronidase
150 Units in 1 mL
Staten Island University Hospital Emergency Department, Staten Island
Children's Hospital at Montefiore, The Bronx
New York Methodist Hospital, Brooklyn
Children's Healthcare of Atlanta, Atlanta
Children's Healthcare of Atlanta - Scottish Rite, Atlanta
North Georgia Clinical Research, Dalton
Arnold Palmer Hospital for Children, Orlando
Tampa General Hospital Children's Medical Center, Tampa
University of Louisville, Louisville
Rainbow Children's and Babies Hospital, Cleveland
Cleveland Clinic Foundation, Cleveland
Memorial Hospital, South Bend
William Beaumont Hospital, Troy
Children's Memorial Hospital, Chicago
The Children's Mercy Hospital & Clinics, Kansas City
Ochsner Clinic Foundation, New Orleans
Children's Medical Center Dallas, Dallas
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital, Houston
Dell Children's Medical Center, Austin
University of New Mexico Health Sciences Center, Albuquerque
Oregon Health & Science University, Portland
Connecticut Children's Medical Center, Hartford
UMDNJ/Robert Wood Johnson Medical School, New Brunswick
St. Joseph's Children's Hospital, Paterson
Lead Sponsor
Baxter Healthcare Corporation
INDUSTRY
Halozyme Therapeutics
INDUSTRY